Stanford University
Showing 381-400 of 2,307 Results
-
Lawrence Crapo
Professor of Medicine (Endocrinology, Gerontology and Metabolism) at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly InterestsInvestigation of the epidemiology of diabetic ketoacidosis (DKA) at a public hospital. All cases of DKA at SCVMC occurring over the past 5 years have been identified. Of the 480 cases of DKA, about 1/3 are in Type II diabetics, and 2/3 in Type I diabetics. We are exploring the causes of DKA in the two groups.
-
Meredith Craven, PhD, MPH
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Craven’s research reflects her background and interests in psychogastroenterology (GI psychology), public health, and positive psychology. She has collaborated on projects across the spectrum of GI disorders, using quantitative and qualitative methods. She is interested in the role of biopsychosocial factors on symptom perception, experience, and related health outcomes and behaviors. In particular, she is passionate about investigating the role of patient strengths that can be fostered clinically, and mind-body practices.
-
Alia Crum
Associate Professor of Psychology and, by courtesy, of Medicine (Primary Care & Population Health)
Current Research and Scholarly InterestsOur lab focuses on how subjective mindsets (e.g., thoughts, beliefs and expectations) can alter objective reality through behavioral, psychological, and physiological mechanisms. We are interested in understanding how mindsets affect important outcomes both within and beyond the realm of medicine, in the domains such as exercise, diet and stress. https://mbl.stanford.edu/
-
Nancy Cuan, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Nancy Cuan is an internal medicine primary care physician at Stanford Coordinated Care (SCC). SCC is a primary care medicine practice that is a benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions. More information, including a self-assessment to determine eligibility based on health condition(s) and health insurance, can be found at the Stanford Coordinated Care website.
Prior to joining Stanford Coordinated Care, she had practiced for many years at Santa Clara Valley Medical Center and helped with the resident training program there. She has had experience in working with patients with multiple ongoing medical conditions. -
Hejie Cui
Postdoctoral Scholar, Biomedical Informatics
BioDr. Hejie Cui is a postdoctoral researcher at the Stanford Center for Biomedical Informatics Research at Stanford University. Her research focuses on the intersection of machine learning, data mining, and biomedical informatics. At Stanford, Dr. Cui works on large language model (LLM) evaluation and post-training for healthcare. Dr. Cui has authored and co-authored several publications in top computer science and interdisciplinary venues, including NeurIPS, KDD, AAAI, CIKM, TMI, and MICCAI. Her work contributes to advancing the application of artificial intelligence in healthcare and improving the understanding of complex biomedical data. Dr. Cui was selected as a Rising Star in EECS in 2023. She has also received numerous awards, including the Fellowship of 2021 CRA-WP Grad Cohort for Women, Student Travel Grant Award for MICCAI'22, NSF Travel Grant for CIKM'22, and NeurIPS AI4Science Travel Award for NeurIPS'22. Dr. Cui holds a Ph.D. in Computer Science from Emory University (2024) and a B.Eng. in Computer Science and Engineering from Tongji University (2019). During her graduate studies, she gained industry experience through internships at Microsoft Research and Amazon Science.
-
Christina Curtis
RZ Cao Professor, Professor of Genetics and of Biomedical Data Science
Current Research and Scholarly InterestsThe Curtis laboratory for Cancer Computational and Systems Biology is focused on the development and application of innovative experimental, computational, and analytical approaches to improve the diagnosis, treatment, and early detection of cancer.
-
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Dahiya is a cancer specialist with board certification in internal medicine, hematology, and medical oncology. He is an Associate Professor at Stanford University School of Medicine and Clinical Director of Cancer Cell Therapy in the Stanford BMT and Cell Therapy division.
Dr. Dahiya strives to support each patient with a personalized and compassionate care plan that optimizes healing and quality of life.
Prior to joining Stanford, Dr. Dahiya was an associate professor of medicine at the Greenebaum Comprehensive Cancer Center at the University of Maryland School of Medicine, where he developed the Cellular Immunotherapy Program and served as the Director of Cellular Immunotherapy in leukemia and lymphoma.
Dr. Dahiya’s research focuses on cellular immunotherapy for hematologic malignancies. He has led and participated in several investigator-initiated studies and sponsored clinical trials with cell therapies (CAR-T, CAR-NK, TCR-T) for hematologic malignancies. His research group is also involved in various translational research activities for the standard of care and research CAR-T therapy. Dr. Dahiya’s group was the first group to show the role of fibrinogen in Neurotoxicity associated with CAR-T therapy. They showed vascular injury as manifested by high fibrinogen levels is associated with higher Neurotoxicity in patients who receive CAR-T therapy. More recently his group led a novel study of assessing the immune response to COVID-19 disease. They evaluated the immune response in critically ill and non-critically ill patients hospitalized with COVID-19 disease and showed a differential immune response between the groups. Dr. Dahiya’s group also showed and established poor immunogenicity of COVID-19 vaccines in CART recipients. As such, passive immunity and other strategies to address the issues of immunogenicity are being explored.
He has published more than 50 articles in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, Blood, Blood Advances, Lancet, Leukemia Research, Neuro-Oncology, and many more. He reviews article submissions for the journals Critical Reviews in Oncology and Hematology, Thoracic Cancer, and Blood. He serves as the hematology lead editor for the journal Critical Reviews in Oncology and Hematology.
He has presented his research findings at conferences such as the annual meetings of the American Society of Hematology, American Society of Clinical Oncology, and American Society for Transplantation and Cell Therapy.
Dr. Dahiya is a member of the American Society of Hematology and the American Society of Transplantation and Cell Therapy. -
Sudeb C. Dalai
Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Sudeb Dalai, MD PhD is an Infectious Disease Physician at Stanford University School of Medicine and the Palo Alto Medical Foundation. Currently a Clinical Assistant Professor (Teaching) at Stanford, he has taught courses and conducted research in academia/industry for over 18 years.
Dr. Dalai completed his undergraduate degree at MIT, MD and MS at Stanford, PhD in Epidemiology at UC Berkeley School of Public Health, Internal Medicine Residency at UCSD, and Fellowship in Infectious Diseases at Stanford. He has received numerous teaching and leadership awards and research grants and has co-authored multiple peer-reviewed publications. His work has been supported by the Infectious Diseases Society of America, the Howard Hughes Medical Institute, the Paul and Daisy Soros Foundation, and the National Institutes of Health. Dr. Dalai is an internationally-invited speaker and has been featured in multiple media outlets including ABC, NBC, Good Morning America, US News & World Report, Buzzfeed, and The Huffington Post. In 2003 he was elected to the MIT Board of Trustees and in 2020 he was voted as a Board Member of the MIT Club of Northern California.